$0.81 EPS Expected for Colgate-Palmolive (NYSE:CL) This Quarter

Equities research analysts expect Colgate-Palmolive (NYSE:CL) to post earnings of $0.81 per share for the current quarter, Zacks Investment Research reports. Five analysts have provided estimates for Colgate-Palmolive’s earnings, with the highest EPS estimate coming in at $0.82 and the lowest estimate coming in at $0.78. Colgate-Palmolive reported earnings per share of $0.74 in the same quarter last year, which suggests a positive year over year growth rate of 9.5%. The company is scheduled to report its next earnings results on Friday, July 30th.

According to Zacks, analysts expect that Colgate-Palmolive will report full-year earnings of $3.28 per share for the current fiscal year, with EPS estimates ranging from $3.24 to $3.34. For the next year, analysts anticipate that the company will report earnings of $3.49 per share, with EPS estimates ranging from $3.41 to $3.55. Zacks’ EPS averages are an average based on a survey of research analysts that follow Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Thursday, April 29th. The company reported $0.80 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.79 by $0.01. Colgate-Palmolive had a return on equity of 298.80% and a net margin of 15.92%. The company had revenue of $4.34 billion during the quarter, compared to analyst estimates of $4.28 billion. During the same quarter in the previous year, the company posted $0.75 earnings per share. Colgate-Palmolive’s revenue was up 6.0% compared to the same quarter last year.

Several analysts recently commented on the company. Zacks Investment Research raised Colgate-Palmolive from a “sell” rating to a “hold” rating and set a $85.00 price objective for the company in a report on Monday, May 3rd. JPMorgan Chase & Co. cut their price target on Colgate-Palmolive from $87.00 to $85.00 and set a “neutral” rating for the company in a report on Friday, April 16th. Credit Suisse Group raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and boosted their price target for the company from $80.00 to $95.00 in a report on Wednesday. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on Colgate-Palmolive from $84.00 to $85.00 and gave the company a “hold” rating in a report on Monday, May 3rd. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $84.42.

In related news, CTO Patricia Verduin sold 46,566 shares of the business’s stock in a transaction dated Wednesday, May 5th. The stock was sold at an average price of $80.89, for a total value of $3,766,723.74. Following the sale, the chief technology officer now directly owns 100,680 shares in the company, valued at $8,144,005.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider John W. Kooyman sold 11,195 shares of the company’s stock in a transaction that occurred on Thursday, May 6th. The shares were sold at an average price of $82.07, for a total value of $918,773.65. Following the sale, the insider now owns 19,251 shares in the company, valued at $1,579,929.57. The disclosure for this sale can be found here. In the last ninety days, insiders sold 91,040 shares of company stock valued at $7,384,255. Corporate insiders own 0.32% of the company’s stock.

Hedge funds have recently modified their holdings of the business. Fisher Asset Management LLC raised its holdings in shares of Colgate-Palmolive by 11.8% in the fourth quarter. Fisher Asset Management LLC now owns 4,909 shares of the company’s stock worth $420,000 after buying an additional 517 shares during the period. Palladium Partners LLC grew its stake in Colgate-Palmolive by 2.2% in the fourth quarter. Palladium Partners LLC now owns 19,349 shares of the company’s stock worth $1,655,000 after purchasing an additional 412 shares in the last quarter. Creative Planning grew its stake in Colgate-Palmolive by 8.4% in the fourth quarter. Creative Planning now owns 91,564 shares of the company’s stock worth $7,830,000 after purchasing an additional 7,134 shares in the last quarter. Stratos Wealth Advisors LLC bought a new position in Colgate-Palmolive in the fourth quarter worth approximately $226,000. Finally, Davy Global Fund Management Ltd grew its stake in Colgate-Palmolive by 2.0% in the fourth quarter. Davy Global Fund Management Ltd now owns 9,463 shares of the company’s stock worth $809,000 after purchasing an additional 182 shares in the last quarter. Institutional investors and hedge funds own 76.01% of the company’s stock.

Shares of CL traded up $1.05 during trading hours on Thursday, hitting $83.61. The stock had a trading volume of 322,151 shares, compared to its average volume of 4,650,496. The company has a debt-to-equity ratio of 11.42, a current ratio of 1.01 and a quick ratio of 0.64. Colgate-Palmolive has a 12 month low of $71.21 and a 12 month high of $86.41. The company has a market cap of $70.73 billion, a price-to-earnings ratio of 26.87, a PEG ratio of 4.26 and a beta of 0.61. The firm has a fifty day moving average price of $81.73.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment's products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items.

Read More: What is an inverted yield curve?

Get a free copy of the Zacks research report on Colgate-Palmolive (CL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.